跳至主要内容
临床试验/NCT03156413
NCT03156413已完成不适用

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea

Fisher and Paykel Healthcare2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2017年5月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
Ease of use

研究概览

简要总结

This investigation is designed to evaluate the performance as well as the patients overall acceptance of the mask.

详细描述

A maximum of 12 OSA participants who currently use a nasal mask will be recruited for the trial. Participant will be on the trial for 1 night (in-lab)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (18+ years of age)
  • Able to give consent
  • Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
  • Prescribed PAP for OSA
  • Existing nasal mask user

排除标准

  • Inability to give consent
  • Patients who are in a coma or a decreased level of consciousness
  • Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
  • Commercial drivers who are investigated by New Zealand Transport Agency
  • Current diagnosis of carbon dioxide (CO2) retention
  • Pregnant or may think they are pregnant

研究组 & 干预措施

F&P Nasal Mask

Experimental

Trial nasal pillows CPAP mask

干预措施: F&P nasal mask (Device)

结局指标

主要结局

Ease of use

时间窗: 1 night

Subjective questionnaire

Acceptability

时间窗: 1 night

Subjective questionnaire

次要结局

  • Objective leak data(1 night)

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验